Ignite Creation Date:
2024-05-05 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00001031
Status:
COMPLETED
Last Update Posted:
2021-11-04
First Post:
1999-11-02
Brief Title:
A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 CHO Chiron Vaccines in MF59 Adjuvant and MN rgp120HIV-1 VaxGen in Alum Adjuvant in Healthy Adults
Sponsor:
Organization:
National Institute of Allergy and Infectious Diseases NIAID